In biology and medicine, this funding is provided by industry. Pharma companies and startups often try to reproduce academic findings before investing into further research
Pharma and biotech startups only make money if a drug works (for the most part), so they tend to have a much higher bar for the robustness of findings than academic researchers and journal editors do.
Of course, this only covers a tiny subset of research
Pharma and biotech startups only make money if a drug works (for the most part), so they tend to have a much higher bar for the robustness of findings than academic researchers and journal editors do.
Of course, this only covers a tiny subset of research